PEMFEXY® (pemetrexed injection)
PEMFEXY is indicated in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous non-small cell lung cancer …
PEMFEXY™ is a folate analog metabolic inhibitor indicated for: • in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic …
COPAY AND FINANCIAL ASSISTANCE – PEMFEXY® (pemetrexed …
The PEMFEXY ® Copay Assistance Program is for commercially insured, eligible patients whose insurance does not cover the full cost of their PEMFEXY ® treatment. Learn more about …
• Commercial Copay Assistance Program for PEMFEXY® ONLY *NOTE: A separate application is required AFTER the referral to the EAGLE CAN PAP Program. Call 1-833-324-5322
PEMFEXY is a folate analog metabolic inhibitor indicated for: • in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous, non -small cell …
PEMFEXY is indicated as a single agent for the treatment of patients with recurrent, metastatic non-squamous non-small cell lung cancer (NSCLC) after prior chemotherapy. Limitation of …
PEMFEXY is indicated as a single agent for the treatment of patients with recurrent, metastatic non-squamous non- small cell lung cancer (NSCLC) after prior chemotherapy.
PEMFEXY is indicated in combination with cisplatin for the initial treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not …
By requesting copay assistance for BELRAPZO or PEMFEXY, you attest that you meet the eligibility criteria, agree to and will comply with the terms and conditions described below: …
PEMFEXY™ is indicated: • in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC). • as a …
Skip to content